DZ-2002(33231-14-0)
- Name: DZ-2002
- Synonyms:methyl 4-(adenin-9-yl)-2-hydroxybutanoate;DZ2002;4-(6-Amino-purin-9-yl)-2-hydroxy-butyric acid methyl ester;(rac)-DZ2002;4-(6-aminopurin-9-yl)-2-hydroxybutyric acid methyl ester;
- Molecular Formula:C10H13N5O3
- Molecular Weight:251.24200
- CAS Registry Number:33231-14-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.33231-14-0 DZ2002
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.33231-14-0 DZ-2002
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:DZ-2002
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.33231-14-0 DZ2002;33231-14-0
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal ChemistryBiomedicinePharmaceutical intermediatesChemistry experimentBiological experimentsChemical reagentFor R&D use only.
Min. Order:10Metric Ton
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)] CAS No.33231-14-0 DZ2002
Assay:>98% Package:inquiry Transportation:inquiry Application:DZ2002 is a potent and reversible S-Adenosyl-L-homocysteine Hydrolase(SAHH; AdoHcy Hydrolase) inhibitor with Ki of 17.9 nM.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 33226-83-4/Manganese, compd. with nickel (1:2)
- 33227-39-3/Hexanoic acid, 6-mercapto-, dodecyl ester
- 33227-91-7/Diazene, (4-butoxyphenyl)(4-methylphenyl)-, (1E)-
- 33227-94-0/Diazene, (4-ethylphenyl)(4-methoxyphenyl)-
- 33228-21-6/Diazene, (4-butylphenyl)(4-propoxyphenyl)-
- 33228-22-7/Diazene, (4-butoxyphenyl)(4-butylphenyl)-
- 33228-23-8/Diazene, (4-butylphenyl)[4-(pentyloxy)phenyl]-
- 33228-25-0/Diazene, (4-butylphenyl)[4-(decyloxy)phenyl]-
- 33228-35-2/Diazene, (4-hexylphenyl)(4-methoxyphenyl)-, (E)-
- 33228-48-7/Phenol, 4-[(4-pentylphenyl)azo]-
- 33228-72-7/1H-Indole-2,3-diol, 1-acetyl-2,3-dihydro-2,3-dimethyl-, trans-
- 33228-99-8/Hexanedioic acid, 2-methylene-, dimethyl ester
- 33229-08-2/Cyclopentanecarboxylic acid, 1-(2-bromoethyl)-2-oxo-, ethyl ester
- 33229-14-0/2H-Indazole-4,7-dione, 2,3-dimethyl-5-(phenylamino)-
- 33229-20-8/2,1-Benzisoxazole-4,7-dione, 3-methyl-5-(phenylamino)-
- 33229-55-9/Methanaminium, N-[4-[[4-(dimethylamino)-3-methylphenyl]phenylmethylene]-2-methyl-2,5 -cyclohexadien-1-ylidene]-N-methyl-
- 33230-60-3/Ethanol, 2,2,2-trichloro-1-(1,1-dimethylethoxy)-
- 33230-61-4/Ethanol, 2,2,2-trichloro-1-(2-methylpropoxy)-
- 33231-13-9/9H-Purine-9-butanoic acid, 6-amino-a-hydroxy-
- 33231-14-0/DZ-2002
- 33231-84-4/1-Propanone, 1-(4,5-dimethoxy-2-nitrophenyl)-3-(4-phenyl-1-piperazinyl)-
- 33232-20-1/Quinazoline, 3,4-dihydro-4-(4-methoxyphenyl)-
- 33233-39-5/Benzoic acid, 2,2-diethylhydrazide
- 33234-37-6/Benzoic acid, 6-amino-2-chloro-3-methoxy-
- 332344-89-5/L-Serine, L-histidyl-L-tyrosyl-L-alanyl-L-methionyl-
- 332344-91-9/L-Serine, L-valyl-L-lysyl-L-leucylglycyl-L-threonyl-L-tyrosyl-L-tyrosyl-L-phenylalanyl-L-a -aspartyl-
- 332344-92-0/L-Serine, L-tyrosyl-L-seryl-L-seryl-L-asparaginyl-L-leucyl-L-histidyl-
- 332344-93-1/L-Threonine, L-histidyl-L-glutaminyl-L-tyrosyl-L-seryl-L-lysyl-L-leucyl-L-prolyl-L-tryptophyl-
- 33234-57-0/1H-Pyrrole, 3-(phenylmethyl)-
- 332347-69-0/Benzeneacetic acid, 3-ethoxy-4-(ethoxycarbonyl)-, ethyl ester